Controlled Release Drug Delivery Market

Report Description
Table of Contents

Report Description

The global market for controlled release drug delivery is expected to be USD 43.76 billion in 2021 and is estimated to witness a CAGR of 8.27% during the forecast period. Increasing requirement for controlled release dosage forms for pediatric and aged population is a key driver for the growth of the global controlled release drug delivery market. Additionally, rise in compliance due to nature of dosage methods and rise in favorable initiatives taken by the government are some of the other drivers propelling the market growth. Nevertheless, inadequate amount of meticulous release dosage forms is acceptable for usage in pediatric treatments and requirement for high dosage of active pharmaceutical ingredient expected to restrain the global market growth.

Global Controlled Release Drug Delivery Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Technology

Based on technology, the market is segmented into implants, Wurster technique, targeted delivery, coacervation, micro encapsulation, transdermal, and others. In 2021, the targeted delivery segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to major players in the market having a strong product range for this technology worldwide. The micro encapsulation segment is expected to grow at a profitable CAGR during the forecast period. This is attributed to the rise in demand to increase the shelf-life and attain controlled drug release for very unstable and complex molecules such as antioxidants, vitamins, and proteins.

By Release Mechanism

Based on release mechanism, the market is segmented into activation-modulated drug delivery systems, polymer-based systems, chemically activated, micro reservoir partition-controlled drug delivery systems, and feedback regulated drug delivery systems. In 2021, the feedback regulated drug delivery systems segment accounted for a substantial revenue share and is anticipated to grow with a lucrative CAGR during the forecast period. This is attributed to the therapeutic effectiveness in the treatment of ailments such as diabetes worldwide. The chemically activated segment is projected to grow at a profitable CAGR during the forecast period. This is attributed with the capability of this segment to react promptly and precisely to the metabolite of interest that results in better-quality drug therapy.

By Application

Based on application, the market is categorized into transdermal and ocular patches, metered dose inhalers, infusion pumps, injectables, oral controlled-drug delivery systems, and drug eluting stents. In 2021, the oral controlled-drug delivery systems segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is due to the rise in the recurrent use and availability of oral controlled drug delivery system worldwide. The metered dose inhalers segment is anticipated to grow at a profitable CAGR during the forecast period, due to the rise in global cases of respiratory disorders, frequent usage of these product, and technological developments.

Regional Insights

In 2021, North America held the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the favorable reimbursement policies by the government, increase in share of healthcare expenditure in the per capita income, growth in initiatives from the government, and accessibility of technologically advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rising incidence of viral diseases, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and new product launches by major pharmaceutical players.

Competitor Insights

Some of the key players in the controlled release drug delivery market are Assertio Therapeutics, Inc. (U.S.); Coating Place, Inc. (U.S.); Corium International, Inc. (U.S.); Johnson and Johnson Services, Inc. (U.S.); Alkermes plc (Ireland); Pfizer, Inc. (U.S.); Orbis Biosciences, Inc. (U.S.); Capsugel (U.S.); Merck and Co., Inc. (U.S.); and Aradigm Corporation (U.S.). The leading players operating in the controlled release drug delivery industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The controlled release drug delivery market report is categorized into the following segments and subsegments: